The gene for the osteolytic toxin of Pasteureffu multocida has been cloned into a plasmid vector and expressed off its own promoter in Escherichia cofi. Particular restriction endonucleases failed to cut the gene and regions flanking it, suggesting an A + T base ratio significantly greater than the remaining genome of P. multocida.
Introduction
Atrophic rhinitis of growing pigs is characterized by atrophy of the nasal turbinate bones which, in the severest form of the disease, is complete and accompanied by the development of twisted or shortened snouts (Switzer & Farrington, 1975) . The disease is also believed to cause a reduction in weight gain (Rutter, 1985) . The severe form of the disease can be detected clinically whilst less severe forms may be seen only at slaughter when turbinate bones can be inspected. Only the severe condition will be referred to as atrophic rhinitis in this paper. Attempts to reproduce atrophic rhinitis were assisted by the discovery of toxigenic isolates of Pasteurella multocida (Il'ina & Zasukhin, 1975; De Jong et al., 1980) . These were identified by the toxicity of cell free extracts for mice and guinea pigs (De Jong et al., 1980) , and for cells grown in vitro (Rutter & Luther, 1984) . Inoculation of pigs with cell free extracts of toxigenic P . multocida either intranasally (Il'ina & Zasukhin, 1975) or intraperitoneally (Rutter & Mackenzie, 1984 ) also reproduced the disease.
The toxin from P. multocida, purified by several groups (Nakai et al., 1984; Chanter et al., 1986b; Rimler & Brogden, 1986; Foged et al., 1986; Kamp et al., 1987) , is a single polypeptide of molecular mass variously quoted as 112 to 160 kDa. Although purified toxin reproduced the symptoms of atrophic rhinitis (Chanter et al., 19846; Dominick & Rimler, 1986 ) its mode of action Abbreviation : EBL, embryonic bovine lung. 0001-5716 O 1990 SGM is unknown. However, preliminary results suggest that it differs from other toxins (Chanter et al., 1986~) . It seemed likely that analysis of the toxin at the molecular level might provide important evidence about its mechanism of action. We describe here the cloning of the toxin gene in Escherichia coli, and the properties of its product.
Methods
Strains and growth conditions. P . multocida strain LFB3 is a toxigenic isolate from a pig with atrophic rhinitis (Rutter, 1983) . E. coli HBlOl harbouring plasmid pAT153 was from Dr J. G. Williams, Imperial Cancer Research Fund, London, UK. All bacteria were stored as cell suspensions at -70 "C in 12% (v/v) glycerol. P . multocida were grown in Bacto-tryptose broth (Jones & Matthews, 1975) at 37°C with agitation. E. coli strains were grown on LB agar or in L broth (Maniatis et al., 1982) .
Chemicals and biochemicals. Restriction enzymes were from BRL or Biolabs, and were used according to the manufacturer's specifications. All other enzymes were from Boehringer. Ampicillin and tetracycline were from Sigma, and agarose from BRL. Adenosine 5'-a-[35S]trithiophosphate ([35S]dATP) was from Amersham. Other chemicals were from BDH.
DNA isolation and cloning techniques. P . multocida DNA was isolated by a modification of the method of Saito & Miura (1963) . Cells were collected by centrifugation and washed in an aqueous solution of 0.15 M-NaCl, 0.1 M-EDTA, pH 8.0, and were resuspended in the same buffer at one-tenth the original volume of culture. Lysozyme (1 mg ml-I) was added, and the mixture was incubated at 37 "C for 30 min and was then rapidly immersed in a dry ice/acetone bath. Eight volumes of lysis solution [O-1 M-Tris/HCl, pH 9, 0.1 M-NaCl, 1 % (w/v) SDS and 50 pg ml-l proteinase K] was added and the mixture was incubated at 60 "C for 10 min before being rapidly frozen in a dry ice/acetone bath. After thawing at 60 "C for 30 min, an equal volume of phenol (Maniatis et al., 1982) was added and the suspension was mixed gently for 1-2 h. The suspension was centrifuged and the aqueous phase was re-extracted with phenol. After phase separation, residual phenol was removed from the aqueous phase by extensive dialysis against an aqueous solution of 50 mM-Tris/HCl, 10 mM-EDTA, 10 mMNaCl, pH 8. The preparation was treated with ribonuclease as described by Maniatis et al. (l982) , and the purified DNA was stored at 4 "C.
Genomic DNA from P. multocida was partially digested with SauIIIA to obtain fragments of about 10 kb. The digest was fractionated on a sucrose gradient as described by Maniatis er a/.
(1 982). Fractions were selected containing fragments in the size range 7-12 kb. The restricted DNA was ligated overnight at 15 "C to pATl53, previously cut with BamHI and treated with phosphatase. Competent HBlOl cells obtained from BRL were transformed and were plated onto L agar containing ampicillin (200 pg ml-I). After incubation at 37 "C overnight, the bacterial colonies obtained (about 6500) were replica-plated onto agar containing tetracycline (12 yg ml-I). About 2500 AprTcs colonies were tested for toxicity for embryonic bovine lung (EBL) cells by the overlay method (Chanter er al., 1986a ) and stored at -70 "C in 12% glycerol in microtitre trays.
Plasmids were isolated according to Ish-Horowitz & Burke (1981) . DNA probes were labelled by nick translation, and other molecular biological techniques were as described in Maniatis et a/. (1982) .
To.uin pur$cation. A crude extract of the toxigenic recombinants TOX I or TOX2, grown on L agar containing ampicillin, was produced by the lysis method of Rimler & Brogden (1986) . Crude extract, treated with R N A ase, D N A ase, benzamidi ne and p heny lmet hy lsulphon yl fluoride was sequentially fractionated by DEAE-Sephacel chromatography and preparative PAGE (Chanter et al., 1986b) . Quantities of toxin in each fraction were measured using toxicity for EBL cells (Rutter & Luther, 1984) .
Characterization of toxin purlfied from recombinant E. coli. The homogeneity and molecular mass of the polypeptide(s) in toxin purified from the recombinants were estimated in 10% polyacrylamide SDS-PAGE (Laemmli, 1970) ; gels were stained with silver as previously described (Chanter et a/., 19866) .
The antigenic similarity of the toxin purified from the E. coli clones with that purified from P. mulrocida was determined. Antiserum to toxin purified from P. multocida was produced in a gnotobiotic pig (Chanter et a/., 1986b) . The toxins were compared in an ELISA, by immunoblotting, by a cytotoxin neutralization test (Rutter & Luther, 1984) and by crossed immunoelectrophoresis by the method of Moore & Rutter (1987) .
In the ELISA, microtitre plates (Falcon -Becton Dickinson) were coated overnight with lOOyl of different concentrations of toxin in 50 mM-carbonate/bicarbonate buffer pH 9-6. Plates were washed in isotonic PBS, pH 7.0, containing 0.03% Tween 20 (PBS/Tween) and incubated at 37°C for 1 h with serial dilutions of pig antiserum in PBS/Tween with 1 % (w/v) dehydrated skimmed milk (Marvel, Cadbury). Plates were washed three times in PBS/Tween and 100 p1 1 : 5000 rabbit anti-swine Ig conjugated to horse radish peroxidase (Nordic Immunological Laboratories) in PBS/Tween/skimmed milk was added to each well and incubated at 37 "C for 3 h. Plates were washed and developed with 100 pl0.04% (w/v) o-phenylenediamine in 0.01 5 % (w/v) hydrogen peroxide buffered with 0.1 5 M-citrate/hydrogen orthophosphate, ?H 5.0 for 15 min; the reaction was stopped with 10 y1 1 M-sulphuric acid. Control wells, excluding either the antigen or the pig antiserum, were treated similarly. Absorbance at 492 nm was measured with a Titertec microplate reader. Control serum was from a specificpathogen-free pig aged 8 weeks.
Proteins separated by SDS-PAGE were immunoblotted by the method of Towbin et al. (1979) using a Transblot apparatus (Bio-Rad).
Toxicity was assayed using EBL cells (Rutter & Luther, 1984) and intraperitoneal injection of gnotobiotic pigs (Rutter & Mackenzie, 1984) and was related to protein content assayed by a Coomassie dye binding method (Bio-Rad).
Trearmenr of'pigs with recombinant toxin. Three litters of gnotobiotic pigs were used to measure toxicity following intraperitoneal inoculation of various quantities of toxin from P. multocida or the E. coliclones. The eight pigs in the first litter were divided into four groups (A-D) when they were 7 d old. Group A was inoculated at 1 pg (kg body weight)-' with toxin purified from P. mulrocida. Group B was inoculated with a cell lysate of recombinant TOXl with a quantity estimated to be approximately 1 pg toxin kg-I, calculated from the toxicity of the lysate for EBL cells, the specific activity of purified toxin and the efficiency of purification. Group C was inoculated at 1 pg kg-' with toxin purified from recombinant TOXl and group D was inoculated with a cell lysate of E. coli HBlOl calculated to be equivalent to 10 times the dose of lysate received by group B.
The second litter, also of eight pigs, was divided into four equal groups (A-D) at 14 days of age. Groups A and D were treated similarly to the same groups of the first litter, but group A was given 200 ng toxin kg-I. Group B received toxin at 200 ng kg-' purified from recombinant TOX2 and group C received the same preparation but at a dose of 400 ng kg-I .
The third litter of six pigs was divided into two groups at 14 d old; group A was given toxin at 440 ng kg-I purified from TOX2 and group B was given a crude extract of E. coli HBlOl containing pAT153.
Pigs were weighed at the start of the experiment and at post mortem 14 d after inoculations with toxin. All pigs in a group were fed the same amount. Damage to turbinate bones was measured by comparison of the ratio of body weight to ventral turbinate weight with that of the control group (D or B) in each case. Kidney and liver were examined for gross signs of damage. Samples of kidney, liver, bladder and ureter were fixed in neutral buffered formalin, embedded in paraffin wax, and sections cut and stained with haematoxylin/eosin. The sections were examined using a light microscope.
Cloning the toxin gene P . rnultocida LFB3 did not contain any plasmids; consequently, the toxin gene was isolated from a gene bank of chromosomal DNA cloned into the plasmid vector pAT153. Of the 2500 AprTcs clones with inserts, one (TOX1) was positive for toxin production. The plasmid from this clone, pAJL12, was purified and transformed into competent E. coli (BRL); 20 transformed bacteria were selected and all were toxigenic.
Analysis of the toxin gene
The plasmid pAJL12 contained a 10.7 kb insert. A physical map of the plasmid was constructed for 19 enzymes (Fig. 1) as follows. The sizes of the fragments generated by each enzyme were determined, and then digestions using two enzymes which each cut only once or twice were performed. It was then possible to map most of the sites by reference to the known restriction sites within the vector (Maniatis et al., 1982) . The other sites were mapped using further combined digestions. The map was unusual since the insert was not cut by HpaII or MspI, and was only cut three times by HaeIII. These three enzymes have a 4 bp recognition sequence which contains only G and C nucleotides. This suggested that the G + C ratio of the DNA might be quite low. The enzymes DraI and SpeI, which have a 6 bp recognition sequence containing only A and T, cut the insert at least 9 and 11 times, respectively (data not shown). Genomic DNA from P. multocida was prepared and cut with HpaI and HpaII, and Southern blots of the gels were probed with the HpaI fragment from the insert in pAJL12. Fig. 2 shows that most of the DNA was digested by HpaII to fragments smaller than 4 kb, but there were discrete bands of higher molecular mass. A band at approximately 15 kb hybridized to the probe. An HpaI fragment of approximately 6 kb reacted with the probe. Three other toxigenic P. multocida isolates produced similar fragments which also reacted with the probe.
The 2500 colonies in the clone bank were also probed with the HpaI fragment, and 12 other colonies hybridized. None produced toxin when tested with the EBL overlay test. Preliminary analysis of the 12 hybridizing colonies showed that they contained plasmids of different sizes.
Su bclon ing
It was not possible to excise the insert from pAJL12, since the BamHI cloning sites in the vector are not always regenerated after cloning SauIIIA-generated fragments. It was therefore decided to use a SauIIIA partial digestion to generate fragments of about 5 kb, the size of the gene predicted from the size of the toxin protein. Fragments of size 5-8 kb were selected and ligated into pATl53. Recombinants were screened for toxicity by the EBL overlay test, and one (TOX2) contained a 5.0 kb insert and produced toxin. The recombinant plasmid (pAJL13) was mapped (Fig. 1) ; its insert was at one end of the insert in pAJL12. The BamHI site in pAJL12, which is probably at the end of the insert, had been transferred to pAJL13, so it was possible that there was a duplication of the vector. Mapping using EcoRIIEcoRV digestion on pAJL12 and EcoRIISalI on pAJL13 showed that if present this was small and less than 0.1 kb (data not shown). The insert in pAJL13 was ligated to the vector in the opposite orientation to pAJL12, which implied that in at least one of the constructs the gene was transcribed from its own promoter.
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PurlJication and properties of the toxin
The cytotoxic recombinants TOXl and TOX2 produced a polypeptide of indistinguishable molecular mass (155 kDa) to that produced by P . multocida. The minimum concentration of purified toxin from TOXl or P . multocida that affected EBL cells was 0.48 ng ml-l and 0.5 ng ml-l, respectively. The yield of both cytotoxicity and toxin protein suggested that TOXl produced approximately five times as much toxin as TOX2 and ten times as much as P. multocida. Like P . multocida both recombinants produced a faint band above the main band. There were other lower molecular mass bands (Fig. 3) , but analysis of SDS-polyacrylamide gels loaded with tenfold dilutions of toxin purified from TOXl or TOX2 indicated that the 155 kDa polypeptide made up 99% of the preparation.
A chequerboard titration of toxin was used to coat the microtitre plate for an ELISA and dilutions of gnotobiotic pig serum against toxin purified from P . multocida were made. The optimum coating concentration of antigen was 1 pg per ml coating buffer for toxin from P . multocida or from either toxigenic recombinant. At this concentration the serum gave an identical titre of lo4 for all toxin preparations. Control serum did not react with any of the toxin preparations.
In a cytotoxin neutralization test the antiserum had a titre of lo3 with 10 cytotoxic units of toxin purified from either P . multocida or the recombinants.
Crossed immunoelectrophoresis of toxin from the recombinants or P. multocidu with gnotobiotic pig antiserum to toxin purified from P . multocida resulted in a precipitate in the basic pattern of one peak which on closer examination was seen to be composed of several closely spaced peaks (Fig. 4) , although only two of these were reproducible. The same preparations in SDS-PAGE stained with silver were composed of only one major band and a fainter band with a slightly higher molecular mass. In immunoblots, antiserum to the toxin purified from P . multocida reacted equally with toxin purified from P . multocida or the toxigenic recombinants, showing a major band of 155 kDa (Fig. 5 ) ; minor bands were seen when the toxin had been stored for several months. Whole-cell lysates from 3 of the 12 recombinants which cross-hybridized with the HpaI fragment of pAJL12, but not HBlOl with the vector, contained three polypeptides which reacted with antibody to toxin (Fig. 5) . These had approximate molecular masses of 76,72 and 48 kDa. The same polypeptides were detected in crude extracts of the toxigenic recombinants TOXl and TOX2. Other bands were seen if a crude extract of E. coli HBlOl containing pATl53 was used as antigen in the SDS-PAGE or if blots were probed only with biotinylated anti-swine IgG and 251-labelled streptavidin, which suggested that their detection was non-specific. The three polypeptides which reacted with antibody to toxin did not appear in either control.
Treatment of pigs with recombinant toxin
Crude or purified toxin from the recombinants was identical in its activity to that purified from P . multocida and was lethal for all but one of the pigs (found dead or killed in extrernis) in the first litter. Extensive damage was caused to the liver and there was hydronephrosis of the kidneys. The surviving pig, which had been given crude toxin from the recombinant, had 59% turbinate atrophy when slaughtered 14 d after inoculation. Control pigs given an extract of E. coli HBlOl containing pAT153 did not show signs of illness or turbinate atrophy. In litters 2 and 3, which were older and given less toxin than the first litter, all pigs survived, without signs of inappetence. There was, however, severe turbinate atrophy in pigs given toxin from P . multocida or the recombinant as well as a reduction in weight gain compared with control pigs (Table 1 ). All pigs given toxin in litter 2 showed signs of snout distortion to the left or right and all pigs given toxin purified from the recombinant had mild brachygnathia superior. The histopathological changes seen in the liver, bladder and ureters were identical to those previously found in pigs given crude toxin (Rutter & Mackenzie, 1984) . The proliferation of the transitional epithelium of the bladder and ureters was most pronounced.
Discussion
nasal cavity. Although in these experiments the toxin was injected intraperitoneally, there is evidence that toxin administered intranasally is able to cause liver damage in some pigs (Dominick & Rimler, 1986) .
The recombinant toxin produced atrophy of the nasal turbinate bones of the pig, and induced considerable liver and kidney damage. There was also marked proliferation of the epithelium of the bladder and ureter as previously described for both unpurified and purified native toxin (Rutter & Mackenzie, 1984; Chanter et al., 19866) . The possibility exists that the toxin exerts these proliferative effects directly.
The gene for the osteolytic toxin of P . multocida has been cloned and expressed in E. coli, and the protein expressed has been shown to have the same properties as the native toxin. In particular, the purified recombinant toxin reproduced severe turbinate atrophy in the pig, which is the key sign of atrophic rhinitis. The 4.9 kb insert in the subclone contains little other than the gene itself, since the predicted size of the toxin gene from the molecular mass of its product (Chanter et a[., 1986b) and the molar ratios of its composite amino acids (Nakai et a[., 1984) would be 4.8 kb. This shows that the P . multocida toxin is sufficient to explain the pathology observed and any mechanism directly involved must be connected to the whole toxin molecule or fragments generated from it.
Restriction data suggested that the insert encoding the toxin was very A + T rich, in contrast to the rest of the P . multocida genome (Carter, 1984) . It was also of interest that the gene was on a HpaII fragment of about 15 kb. This suggested that a simple method of cloning this gene or variants of it would be to extract the large HpaII fragment and insert it into a suitable vector. The significance of the abnormal base ratio is not clear, but could perhaps reflect a difference between the toxin gene and its flanking sequences and the remaining P . multocida genome. The gene was expressed at a high level in E. coli, and produced about 15 % of the total protein in one of the recombinants. The gene was not found in nontoxigenic P . multocida (unpublished observations). The significance of additional polypeptides produced by the toxigenic recombinants, and the non-toxigenic recombinants containing part of the gene, is unknown. These polypeptides are not found in toxigenic P . multocida either in crude extracts or in purified toxin prepared by either affinity chromatography (Chanter et al., 1986c) or immunoabsorbent chromatography using a monoclonal antibody (Foged, 1988) . Since the insert in pAJL13 was only just large enough to encode the whole toxin, the additional polypeptides antigenically related to the toxin must have been encoded by the toxin gene. This suggests that there are either initiation or stop signals within the gene that are not utilized by P . multocida but which are recognized by the E. coli transcription system. Alternatively there might be posttranslational breakdown of the protein in E. coli.
The toxin purified from the recombinant TOX2 was able to reduce weight gain compared with controls without affecting food consumption. Therefore the association of atrophic rhinitis with poor economic performance might, like turbinate atrophy, have a molecular basis ultimately dependent on the toxin of P . multocida. For such an effect in the natural disease the toxin would have to gain entry to the circulation from the We thank Jeff Williams (ICRF) for much useful advice and Ingrid Aitken for technical assistance.
